UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Birth incidence and prevalence of tumor-prone syndromes: Estimates from a UK family genetic register service

American journal of medical genetics. Part A, 2010-02, Vol.152A (2), p.327-332

2010

Volltextzugriff (PDF)

Familial Breast Cancer

Clinical genetics, 2012-08, Vol.82 (2), p.105-114

2012

Volltextzugriff (PDF)

Systematic review of the impact of registration and screening on colorectal cancer incidence and mortality in familial adenomatous polyposis and Lynch syndrome

British journal of surgery, 2013-12, Vol.100 (13), p.1719-1731

2013

Volltextzugriff (PDF)

Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations

Familial cancer, 2012-06, Vol.11 (2), p.235-242

2012

Volltextzugriff (PDF)

Colonoscopy screening compliance and outcomes in patients with Lynch syndrome

Colorectal disease, 2015-01, Vol.17 (1), p.38-46

2015

Volltextzugriff (PDF)

Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer

Journal of medical genetics, 2011-08, Vol.48 (8), p.520-522

2011

Volltextzugriff (PDF)

Low prevalence of HER2 positivity amongst BRCA1 and BRCA2 mutation carriers and in primary BRCA screens

Breast cancer research and treatment, 2016-02, Vol.155 (3), p.597-601

2016

Volltextzugriff (PDF)

Tumour MLH1 promoter region methylation testing is an effective prescreen for Lynch Syndrome (HNPCC)

Journal of medical genetics, 2014-12, Vol.51 (12), p.789-796

2014

Volltextzugriff (PDF)

Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations

Clinical genetics, 2009-02, Vol.75 (2), p.141-149

2009

Volltextzugriff (PDF)

Patient reported outcome measures in a cohort of patients at high risk of breast cancer treated by bilateral risk reducing mastectomy and breast reconstruction

Journal of plastic, reconstructive & aesthetic surgery, 2022-01, Vol.75 (1), p.69-76

2022

Volltextzugriff (PDF)

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions

British journal of cancer, 2008-04, Vol.98 (8), p.1457-1466

2008

Volltextzugriff (PDF)

Risk of breast cancer in male BRCA2 carriers

Journal of medical genetics, 2010-10, Vol.47 (10), p.710-711

2010

Volltextzugriff (PDF)

Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancers

Journal of medical genetics, 2009-09, Vol.46 (9), p.593-597

2009

Volltextzugriff (PDF)

Menopausal symptoms and bone health in women undertaking risk reducing bilateral salpingo-oophorectomy: significant bone health issues in those not taking HRT

British journal of cancer, 2011-06, Vol.105 (1), p.22-27

2011

Volltextzugriff (PDF)

Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies

American journal of human genetics, 2003-05, Vol.72 (5), p.1117-1130

2003

Volltextzugriff (PDF)

Genotype-phenotype correlation in colorectal polyposis

Clinical genetics, 2012-06, Vol.81 (6), p.521-531

2012

Volltextzugriff (PDF)

Long-term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA1/BRCA2/TP53 status

British journal of cancer, 2010-03, Vol.102 (7), p.1091-1098

2010

Volltextzugriff (PDF)

Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing

Journal of medical genetics, 2009-12, Vol.46 (12), p.811-817

2009

Volltextzugriff (PDF)

Risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a 30-year semi-prospective analysis

Familial cancer, 2015-12, Vol.14 (4), p.531-538

2015

Volltextzugriff (PDF)

Young age at first pregnancy does protect against early onset breast cancer in BRCA1 and BRCA2 mutation carriers

Breast cancer research and treatment, 2018-02, Vol.167 (3), p.779-785

2018

Volltextzugriff (PDF)

Are women with pathogenic variants in PMS2 and MSH6 really at high lifetime risk of breast cancer?

Genetics in medicine, 2019-08, Vol.21 (8), p.1878-1879

2019

Volltextzugriff (PDF)

Uptake of risk-reducing salpingo-oophorectomy in women carrying a BRCA1 or BRCA2 mutation: evidence for lower uptake in women affected by breast cancer and older women

British journal of cancer, 2012-02, Vol.106 (4), p.775-779

2012

Volltextzugriff (PDF)

A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO

Journal of medical genetics, 2004-06, Vol.41 (6), p.474-480

2004

Volltextzugriff (PDF)

Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme

Journal of medical genetics, 2003-11, Vol.40 (11), p.807-814

2003

Volltextzugriff (PDF)

Improving the uptake of predictive testing and colorectal screening in Lynch syndrome: a regional primary care survey

Clinical genetics, 2015-06, Vol.87 (6), p.517-524

2015

Volltextzugriff (PDF)

1 – 25 von 291

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(284)
Mit Volltextzugriff
(257)

Publikationsform

Sprache

Englisch
(291)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Birth incidence and prevalence of tumor-prone syndromes: Estimates from a UK family genetic register service

Familial Breast Cancer

Systematic review of the impact of registration and screening on colorectal cancer incidence and mortality in familial adenomatous polyposis and Lynch syndrome

Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations

Colonoscopy screening compliance and outcomes in patients with Lynch syndrome

Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer

Low prevalence of HER2 positivity amongst BRCA1 and BRCA2 mutation carriers and in primary BRCA screens

Tumour MLH1 promoter region methylation testing is an effective prescreen for Lynch Syndrome (HNPCC)

Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations

Patient reported outcome measures in a cohort of patients at high risk of breast cancer treated by bilateral risk reducing mastectomy and breast reconstruction

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions

Risk of breast cancer in male BRCA2 carriers

Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancers

Menopausal symptoms and bone health in women undertaking risk reducing bilateral salpingo-oophorectomy: significant bone health issues in those not taking HRT

Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies

Genotype-phenotype correlation in colorectal polyposis

Long-term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA1/BRCA2/TP53 status

Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing

Risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a 30-year semi-prospective analysis

Young age at first pregnancy does protect against early onset breast cancer in BRCA1 and BRCA2 mutation carriers

Are women with pathogenic variants in PMS2 and MSH6 really at high lifetime risk of breast cancer?

Uptake of risk-reducing salpingo-oophorectomy in women carrying a BRCA1 or BRCA2 mutation: evidence for lower uptake in women affected by breast cancer and older women

A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO

Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme

Improving the uptake of predictive testing and colorectal screening in Lynch syndrome: a regional primary care survey

Suchergebnisse filtern